AzTrials
AzTrials

Irregular Heart RateNCT00165932

Ventricular Synchrony in Pediatric Patients

An observational study of Irregular Heart Rate, run by Emory University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

At Children's Healthcare of Atlanta, children who have irregular heart rhythms are often referred for evaluation. Sometimes they also need a procedure to correct their irregular heart rhythm. An echocardiogram is routinely used as part of their evaluation and follow-up. Read more about this study

Who is it for?
Any age
Conditions the study is for
Irregular Heart Rate
How many people
145 participants
Where
1 siteUnited States
Study dates
Jun 2004to Dec 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: We are currently only enrolling those patients with the diagnosis of SVT who are scheduled for an electrophysical study at Children's Healthcare of Atlanta Egleston Campus.

Who may be able to join

  • Any pediatric patient already referred for EPS and possible RFA at Children's Healthcare of Atlanta for the following diagnoses:
  • Non-preexcited supraventricular tachycardia
  • Atrioventricular Node Reentrant Tachycardia (AVNRT)
  • Atrioventricular Reentry Tachycardia (AVRT) utilizing a concealed AC
  • Atrial Flutter
  • Wolff-Parkinson-White syndrome (WPW)
  • Ventricular tachycardia with structurally normal hearts with normal function We will also be enrolling young adult subjects who will be recruited for participation. -

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Healthcare of Atlanta at Egleston

    Atlanta, Georgia, 30322

Other trials in United States

About this study

Official title: A Single Center Prospective, Pilot Study Examining the Non-invasive Evaluation of Ventricular Synchrony in Pediatric Patients

At Children's Healthcare of Atlanta, children who have irregular heart rhythms are often referred for evaluation. Sometimes they also need a procedure to correct their irregular heart rhythm. An echocardiogram is routinely used as part of their evaluation and follow-up. The echocardiogram including Tissue Doppler Imaging (TDI) works by bouncing sound waves off the heart similar to radar. A new echocardiogram technology, Tissue Synchronization Imaging (TSI), should help doctors look at heart function compared to heart rhythm. All three of these are noninvasive, which means they work from a probe outside the body and are not painful.

The purpose of this study is to see how Tissue Synchronization Imaging works in patients with heart rhythm problems. We will use patients who have a heart irregularity. We will also look at children and young adults with normal heart function to establish normal values for TSI.

All pediatric patients we approach for this study will receive an echocardiogram recommended by their cardiologist (standard of care), plus TSI, a new part of a heart ultrasound The young adult population will undergo a heart ultrasound plus TSI. This young adult population will be selected from medical students at Emory University. During the consent process, the medical students will be informed that participation is voluntary and if they decide not to participate, it will not affect their grades, etc.

Read the detailed description

There is a growing body of evidence that interventricular dyssynchrony results in abnormal ventricular mechanics that may be detrimental to myocardial performance.(1; 2) Adult patients with LBBB, dilated cardiomyopathy and CHF are increasingly being treated with a novel pacing technique in order to restore electrical and mechanical synchrony.(3-5) This technique, biventricular or resynchronization pacing, involves the insertion of a specialized cardiac pacing system that not only maintains atrioventricular synchrony, but also restores interventricular synchrony by simultaneously activating the right and left ventricles. There have been a number of clinical trials (MIRACLE, MUSTT, INSYNC) that have revealed marked clinical improvement in adult patients with moderate-to-severe CHF.(6-8) There have been a few small reports of the acute effects of biventricular pacing in pediatric patients with acquired interventricular dysynchrony either from repair or palliation of congenital heart defects, or from chronic standard pacing from one ventricular chamber (single-site ventricular pacing).(9-11) One of the main hurdles encountered when evaluating these patients is the lack of reliable, reproducible non-invasive imaging modalities. Recent reports have shown promising results with a relatively new technique known as tissue Doppler imaging (TDI).(12-14) TDI echocardiography has recently been employed as a non-geometric measure of myocardial systolic and diastolic performance for both the left and the right ventricles. Utilizing low velocity signals from discrete points on the myocardial walls, motion can be assessed under a variety of conditions non-invasively. Additionally when two points along a ventricular wall are simultaneously assayed, the relative motion between the two points can estimate myocardial systolic strain in the direction of the Doppler sound beam. This technique eliminates any variation due to the translational motion of the heart.

Tissue synchronization can be assessed by the timing of peak systolic motion of different points along the myocardium relative either to the QRS of the electrocardiogram or to the mechanical indicators of systole such as aortic valve opening. Recent advances in software design have now created technology that simultaneously depicts the peak velocities of the entire myocardium viewed in a 2-dimensional echo image. This promotes easy identification of any dysynchronous segments. By subsequently applying discrete cursors to these areas, graphic patterns of both velocity and direction of myocardial motion can be drawn for quantitative analysis. The application of these new sophisticated tools will allow better analysis of electromechanical dysynchrony and may enable definition of criteria, which can be used to identify those patients who will or will not benefit from cardiac resynchronization therapy.

We have identified 4 groups of patients that will allow us to prospectively and systematically evaluate TSI in this young population. The first group is those patients with supraventricular tachycardia and the Wolff-Parkinson-White (WPW) syndrome. These patients have an accessory AV connection (AC) that allows electrical activity to bypass the normal AV node and excite the ventricles prematurely. In doing so, the result is a loss of the normal, midline ventricular activation pattern for a dysynchronous activation pattern. There have been small reports of this chronic ventricular dysynchrony potential playing a role in depressed myocardial performance.(15) Standard therapy for patients with WPW and clinical SVT includes invasive intracardiac electrophysiology study (EPS) with possible radiofrequency ablation (RFA) in order to eliminate the AC. These patients are then left with normal conduction over the AV node, presumably restoring the midline activation sequence.

The second group of patients is those children with SVT and no evidence of ventricular preexcitation (i.e., no WPW). These patients have a normal, midline ventricular activation pattern in sinus rhythm. Standard treatment for children afflicted with these variants of SVT would also include EPS and RFA. As part of the standard EPS, these patients receive intermittent atrial and ventricular pacing. The result of the transient ventricular pacing is presumably a dysynchronous activation pattern that could be evaluated with TSI. With pacing off, the normal activation pattern should be restored. Therefore, these patients will also serve as their own controls.

The third group is essentially normal (normal 4 chamber anatomy) pediatric patients who have been referred for an echocardiogram to evaluate a possible heart murmur, syncope or chest pain. Their data will be used to establish normal pediatric values for TSI.

The fourth group is normal (normal 4 chamber anatomy) young adult subjects who will be recruited for participation in this study. Their data will be used to establish normal adult values for TSI. These values or results will not be compared to the other three pediatric groups.

Keywords
tachycardia, pediatrics
Medical subject headings
Arrhythmias, Cardiac, Tachycardia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2005 (estimated)
  2. Study startJun 2004
  3. Primary completionDec 2009
  4. Study completionDec 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
145 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00165932
Sponsor's protocol ID
417-2004
Status last verified
May 2012
First submitted
9 Sep 2005
Last updated
1 Jun 2012
Results posted
No
Data monitoring committee
No

Publications

  • Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol. 2003 Aug 20;42(4):614-23. doi: 10.1016/s0735-1097(03)00757-5.

    PubMed 12932590
  • Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002 Dec 25;288(24):3115-23. doi: 10.1001/jama.288.24.3115.

    PubMed 12495391
  • Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002 Jun 13;346(24):1845-53. doi: 10.1056/NEJMoa013168.

    PubMed 12063368
  • Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001 Mar 22;344(12):873-80. doi: 10.1056/NEJM200103223441202.

    PubMed 11259720

Questions about this trial

What is this clinical trial studying?

An observational study of Irregular Heart Rate, run by Emory University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00165932, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jun 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in